Patients with Medicaid or no insurance may have worse survival outcomes compared with Medicare or private insurance in those with metastatic renal cell carcinoma. Patients with metastatic renal cell ...

The approval of immune checkpoint inhibitors (ICIs) was associated with a significant improvement in 2-year overall survival among patients with advanced-stage melanoma, non-small cell lung cancer ...

Marissa Russo is a former STAT intern supported by the AAAS Mass Media Science & Engineering Fellowship. As a cancer patient, access to innovative drugs can help extend your life — that is if you have ...

Split-Dose Cisplatin Plus Atezolizumab for Patients With Urothelial Carcinoma Who Are Considered Ineligible for Full Doses of Cisplatin (SOGUG-AUREA) In patients with mRCC, Medicare was associated ...